124 related articles for article (PubMed ID: 38691085)
1. The Risk of Kidney Injury in Patients With Sickle Cell Disease Treated With Ketorolac for Acute Pain.
Harris EM; Oni MO; Donado C; Heeney MM; Solodiuk J; Greco C; Archer NM
J Pediatr Hematol Oncol; 2024 Jul; 46(5):e290-e295. PubMed ID: 38691085
[TBL] [Abstract][Full Text] [Related]
2. Acute kidney injury during a pediatric sickle cell vaso-occlusive pain crisis.
Baddam S; Aban I; Hilliard L; Howard T; Askenazi D; Lebensburger JD
Pediatr Nephrol; 2017 Aug; 32(8):1451-1456. PubMed ID: 28238158
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of ketorolac continuous infusion for multimodal analgesia of vaso-occlusive crisis in patients with sickle cell disease.
Pinto VM; Gianesin B; Sardo S; Mazzi F; Baiardi G; Menotti S; Piras F; Quintino S; Robello G; Mattioli F; Finco G; Forni GL; De Franceschi L
Orphanet J Rare Dis; 2024 Jan; 19(1):22. PubMed ID: 38254184
[TBL] [Abstract][Full Text] [Related]
4. Effect of ketorolac in pediatric sickle cell vaso-occlusive pain crisis.
Hardwick WE; Givens TG; Monroe KW; King WD; Lawley D
Pediatr Emerg Care; 1999 Jun; 15(3):179-82. PubMed ID: 10389953
[TBL] [Abstract][Full Text] [Related]
5. Ketorolac Use for Pain Management in Trauma Patients With Rib Fractures Does not Increase of Acute Kidney Injury or Incidence of Bleeding.
Torabi J; Kaban JM; Lewis E; Laikhram D; Simon R; DeHaan S; Jureller M; Chao E; Reddy SH; Stone ME
Am Surg; 2021 May; 87(5):790-795. PubMed ID: 33231476
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological interventions for painful sickle cell vaso-occlusive crises in adults.
Cooper TE; Hambleton IR; Ballas SK; Johnston BA; Wiffen PJ
Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31742673
[TBL] [Abstract][Full Text] [Related]
7. Acute kidney injury in paediatric patients with sickle cell disease is associated with increased morbidity and resource utilization.
McCormick M; Richardson T; Warady BA; Novelli EM; Kalpatthi R
Br J Haematol; 2020 May; 189(3):559-565. PubMed ID: 32030722
[TBL] [Abstract][Full Text] [Related]
8. Intravenous ketorolac in the emergency department management of sickle cell pain and predictors of its effectiveness.
Beiter JL; Simon HK; Chambliss CR; Adamkiewicz T; Sullivan K
Arch Pediatr Adolesc Med; 2001 Apr; 155(4):496-500. PubMed ID: 11296078
[TBL] [Abstract][Full Text] [Related]
9. Fentanyl Buccal Tablet: A New Breakthrough Pain Medication in Early Management of Severe Vaso-Occlusive Crisis in Sickle Cell Disease.
De Franceschi L; Mura P; Schweiger V; Vencato E; Quaglia FM; Delmonte L; Evangelista M; Polati E; Olivieri O; Finco G
Pain Pract; 2016 Jul; 16(6):680-7. PubMed ID: 26009799
[TBL] [Abstract][Full Text] [Related]
10. Subclinical myocardial injury during vaso-occlusive crisis in pediatric sickle cell disease.
Wagdy R; Suliman H; Bamashmose B; Aidaroos A; Haneef Z; Samonti A; Awn F
Eur J Pediatr; 2018 Dec; 177(12):1745-1752. PubMed ID: 30194527
[TBL] [Abstract][Full Text] [Related]
11. Ketorolac-induced irreversible renal failure in sickle cell disease: a case report.
Simckes AM; Chen SS; Osorio AV; Garola RE; Woods GM
Pediatr Nephrol; 1999 Jan; 13(1):63-7. PubMed ID: 10100293
[TBL] [Abstract][Full Text] [Related]
12. Ketorolac-associated renal morbidity: risk factors in cardiac surgical infants.
Moffett BS; Cabrera A
Cardiol Young; 2013 Oct; 23(5):752-4. PubMed ID: 23088994
[TBL] [Abstract][Full Text] [Related]
13. Demand-only patient-controlled analgesia for treatment of acute vaso-occlusive pain in sickle cell disease.
Carullo V; Morrone K; Weiss M; Choi J; Gao Q; Pisharoty S; Moody K; Manwani D
Pediatr Blood Cancer; 2022 Aug; 69(8):e29665. PubMed ID: 35294090
[TBL] [Abstract][Full Text] [Related]
14. Low dose ketamine versus morphine for acute severe vaso occlusive pain in children: a randomized controlled trial.
Lubega FA; DeSilva MS; Munube D; Nkwine R; Tumukunde J; Agaba PK; Nabukenya MT; Bulamba F; Luggya TS
Scand J Pain; 2018 Jan; 18(1):19-27. PubMed ID: 29794277
[TBL] [Abstract][Full Text] [Related]
15. Ketamine use for management of vaso-occlusive pain in pediatric sickle cell disease.
Harris EM; Vilk E; Donado C; Williams A; Heeney MM; Solodiuk J; Greco C; Archer NM
Pediatr Blood Cancer; 2023 May; 70(5):e30254. PubMed ID: 36861789
[TBL] [Abstract][Full Text] [Related]
16. Acute kidney injury in children with sickle cell disease-compounding a chronic problem.
Mammen C; Bissonnette ML; Matsell DG
Pediatr Nephrol; 2017 Aug; 32(8):1287-1291. PubMed ID: 28353009
[TBL] [Abstract][Full Text] [Related]
17. A pilot study on the efficacy of ketorolac plus tramadol infusion combined with erythrocytapheresis in the management of acute severe vaso-occlusive crises and sickle cell pain.
de Franceschi L; Finco G; Vassanelli A; Zaia B; Ischia S; Corrocher R
Haematologica; 2004 Nov; 89(11):1389-91. PubMed ID: 15531461
[TBL] [Abstract][Full Text] [Related]
18. Acute kidney injury in hospitalized children with sickle cell anemia.
Batte A; Menon S; Ssenkusu J; Kiguli S; Kalyesubula R; Lubega J; Mutebi EI; Opoka RO; John CC; Starr MC; Conroy AL
BMC Nephrol; 2022 Mar; 23(1):110. PubMed ID: 35303803
[TBL] [Abstract][Full Text] [Related]
19. Risk of Acute Kidney Injury After Primary and Revision Total Hip Arthroplasty and Total Knee Arthroplasty Using a Multimodal Approach to Perioperative Pain Control Including Ketorolac and Celecoxib.
Warth LC; Noiseux NO; Hogue MH; Klaassen AL; Liu SS; Callaghan JJ
J Arthroplasty; 2016 Jan; 31(1):253-5. PubMed ID: 26377377
[TBL] [Abstract][Full Text] [Related]
20. Ketorolac for postoperative pain in children.
McNicol ED; Rowe E; Cooper TE
Cochrane Database Syst Rev; 2018 Jul; 7(7):CD012294. PubMed ID: 29981164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
